Tuesday Pfizer announced it's expanding its clinical trials for younger children ages 5 to 11-years-old. Medical doctors are calling this the final frontier. This is a 2-year study, where a subset of ...
Pfizer says COVID vaccine protection lasts at least 6 months; Company can now seek full FDA approval
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results